NCT03604718 - Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions

Rhinoconjunctivitis With or Without Allergic Asthma

Interventions

BIOLOGICAL

Beltavac® Polymerized with Alternaria alternata

Adminstration of Beltavac® Polymerized with Alternaria alternata according to the routine clinical practice

Trial Locations (13)

University Hospital Virgen de la Arrixaca, Murcia

Universitary Hospital of Vic, Vic

Medical Center Fedear, Barcelona

University Hospital of Torrejon, Torrejón de Ardoz

University Hospital of Cartagena, Cartagena

Clínica de Alergia Mar Jiménez Lara, Talavera de la Reina

Allergo Centre, Barcelona

Medical Center Cenvi Medic, Barcelona

Alergomundo, Madrid

Clinica Torrelodones, Madrid

Ojeda Clinic, Madrid

Reina Sofia Universitary Hospital, Murcia

Clinica Alergologica Dr Moral, Toledo

All Listed Sponsors

lead

Probelte Pharma S.L.U.

INDUSTRY